These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39293714)

  • 21. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects.
    Vara D; Tarafdar A; Celikag M; Patinha D; Gulacsy CE; Hounslea E; Warren Z; Ferreira B; Koeners MP; Caggiano L; Pula G
    FASEB J; 2020 Oct; 34(10):13959-13977. PubMed ID: 32851720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Platelet Function and Thrombus Formation in PDE5A-Deficient Mice.
    Gui X; Chu X; Du Y; Wang Y; Zhang S; Ding Y; Tong H; Xu M; Li Y; Ju W; Sun Z; Li Z; Zeng L; Xu K; Qiao J
    Thromb Haemost; 2023 Feb; 123(2):207-218. PubMed ID: 36252813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
    Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
    Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel combinatorial technique for simultaneous quantification of oxygen radicals and aggregation reveals unexpected redox patterns in the activation of platelets by different physiopathological stimuli.
    Vara D; Cifuentes-Pagano E; Pagano PJ; Pula G
    Haematologica; 2019 Sep; 104(9):1879-1891. PubMed ID: 30679320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eisenia bicyclis (brown alga) modulates platelet function and inhibits thrombus formation via impaired P
    Irfan M; Kwon TH; Yun BS; Park NH; Rhee MH
    Phytomedicine; 2018 Feb; 40():79-87. PubMed ID: 29496178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
    Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
    Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of focal adhesion tyrosine kinases in GPVI-dependent platelet activation and reactive oxygen species formation.
    Carrim N; Walsh TG; Consonni A; Torti M; Berndt MC; Metharom P
    PLoS One; 2014; 9(11):e113679. PubMed ID: 25415317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase.
    Liu Y; Hu M; Luo D; Yue M; Wang S; Chen X; Zhou Y; Wang Y; Cai Y; Hu X; Ke Y; Yang Z; Hu H
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2075-2086. PubMed ID: 28882875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
    Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activity.
    Smith CW; Harbi MH; Garcia-Quintanilla L; Rookes K; Brown H; Poulter NS; Watson SP; Nicolson PLR; Thomas MR
    J Thromb Haemost; 2022 Dec; 20(12):2939-2952. PubMed ID: 36239466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
    Yokomori R; Shirai T; Tsukiji N; Oishi S; Sasaki T; Takano K; Suzuki-Inoue K
    Platelets; 2023 Dec; 34(1):2281941. PubMed ID: 38010137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
    Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
    Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets.
    Violi F; Pastori D; Carnevale R; Pignatelli P
    Curr Pharm Des; 2015; 21(41):5945-50. PubMed ID: 26510431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation.
    Wang Y; Wu YP; Han JJ; Zhang MQ; Yang CX; Jiao P; Tian H; Zhu C; Qin SC; Sun XJ; Zhang HT; Zhao XM
    Life Sci; 2019 Sep; 233():116700. PubMed ID: 31356907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional role of NADPH oxidase in activation of platelets.
    Chlopicki S; Olszanecki R; Janiszewski M; Laurindo FR; Panz T; Miedzobrodzki J
    Antioxid Redox Signal; 2004 Aug; 6(4):691-8. PubMed ID: 15242549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids control platelet activation and limit aggregate formation under flow.
    De Angelis V; Koekman AC; Weeterings C; Roest M; de Groot PG; Herczenik E; Maas C
    PLoS One; 2014; 9(9):e108282. PubMed ID: 25264625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.